Moreover, some differences can be found in the immunological profile of biopsy samples: in a study of patients with CIC induced by anti-CTLA-4, a higher prevalence of CD4+ T cells was reported compared to IBD patients’ samples, where the Treg cells were more frequent [52]. This evidence concerns the gene CTLA4 and inflammatory bowel disease.